Literature DB >> 9391995

Hormone replacement therapy and intraocular pressure.

M O Sator1, E A Joura, P Frigo, C Kurz, M Metka, A Hommer, J C Huber.   

Abstract

OBJECTIVES: To evaluate the effect of hormone replacement therapy (HRT) on intraocular pressure (IOP) in menopausal women.
METHODS: The IOP of 25 white menopausal women without an abnormal ophthalmologic history was measured before and during HRT regimen. IOP fluctations were recorded before and 1, 4, and 12 weeks after the beginning of HRT. These measurements were obtained according to a standardized time schedule (08:00, 12:00, 16:00, and 19:00 h).
RESULTS: The mean IOP in the left eye decreased from 16.2 +/- 2.4 mmHg before therapy to 14.0 +/- 2.1 mmHg after 12 weeks of therapy (P < 0.001). In the right eye, whose IOP was at 15.3 +/- 2.3 mmHg before therapy there was a decrease to 14.0 +/- 1.9 mmHg after 12 weeks of therapy (P < 0.001).
CONCLUSION: Hormone replacement therapy has a positive effect on IOP in menopausal women.

Entities:  

Mesh:

Year:  1997        PMID: 9391995     DOI: 10.1016/s0378-5122(97)00060-1

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  28 in total

1.  Female reproductive factors and open angle glaucoma: the Blue Mountains Eye Study.

Authors:  A J Lee; P Mitchell; E Rochtchina; P R Healey
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

2.  Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma in Caucasians from the USA.

Authors:  Janey L Wiggs; Jae Hee Kang; Brian L Yaspan; Daniel B Mirel; Cathy Laurie; Andrew Crenshaw; Wendy Brodeur; Stephanie Gogarten; Lana M Olson; Wael Abdrabou; Elizabeth DelBono; Stephanie Loomis; Jonathan L Haines; Louis R Pasquale
Journal:  Hum Mol Genet       Date:  2011-08-26       Impact factor: 6.150

3.  A nested case control study of plasma ICAM-1, E-selectin and TNF receptor 2 levels, and incident primary open-angle glaucoma.

Authors:  Jae H Kang; Janey L Wiggs; Louis R Pasquale
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-11       Impact factor: 4.799

4.  The potential association between postmenopausal hormone use and primary open-angle glaucoma.

Authors:  Paula Anne Newman-Casey; Nidhi Talwar; Bin Nan; David C Musch; Louis R Pasquale; Joshua D Stein
Journal:  JAMA Ophthalmol       Date:  2014-03       Impact factor: 7.389

5.  Sex hormone levels and risk of primary open-angle glaucoma in postmenopausal women.

Authors:  Jae Hee Kang; Bernard A Rosner; Janey L Wiggs; Louis R Pasquale
Journal:  Menopause       Date:  2018-10       Impact factor: 2.953

Review 6.  Is Estrogen a Therapeutic Target for Glaucoma?

Authors:  Samantha S Dewundara; Janey L Wiggs; David A Sullivan; Louis R Pasquale
Journal:  Semin Ophthalmol       Date:  2016       Impact factor: 1.975

Review 7.  Gender and glaucoma: what we know and what we need to know.

Authors:  Thasarat S Vajaranant; Sushma Nayak; Jacob T Wilensky; Charlotte E Joslin
Journal:  Curr Opin Ophthalmol       Date:  2010-03       Impact factor: 3.761

8.  Expression of estrogen receptor alpha and 17beta-hydroxysteroid dehydrogenase 4 in the ciliary body.

Authors:  Kaori Kobayashi; Ryo Iwakiri; Hiroshi Kobayashi; Satoshi Okinami
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-11-21       Impact factor: 3.117

9.  Endothelial nitric oxide synthase gene variants and primary open-angle glaucoma: interactions with sex and postmenopausal hormone use.

Authors:  Jae Hee Kang; Janey L Wiggs; Bernard A Rosner; Susan E Hankinson; Wael Abdrabou; Bao Jian Fan; Jonathan Haines; Louis R Pasquale
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-08       Impact factor: 4.799

10.  Effects of Hormone Therapy on Intraocular Pressure: The Women's Health Initiative-Sight Exam Study.

Authors:  Thasarat S Vajaranant; Pauline M Maki; Louis R Pasquale; Anne Lee; Hajwa Kim; Mary N Haan
Journal:  Am J Ophthalmol       Date:  2016-03-03       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.